Rabeprazole Impurities

veeprho banner
Parent Drug Name Name of Impurity Catalogue No.
Rabeprazole Benzimidazole VL970014View CAS 51-17-2
Rabeprazole Rabeprazole EP Impurity D VL970001View CAS 924663-40-1
Rabeprazole Rabeprazole EP Impurity E VL970013View CAS 102804-77-3
Rabeprazole Rabeprazole EP Impurity G VL970010View CAS 102804-82-0
Rabeprazole Rabeprazole EP Impurity I VL970003View CAS 924663-37-6
Rabeprazole Rabeprazole Picolinium Salt Impurity VE006108View CAS 1807988-36-8
Rabeprazole Rabeprazole Related Compound D VL970007View CAS 117976-47-3
Rabeprazole Rabeprazole Related Compound E VL970008View CAS 117977-21-6
Rabeprazole Rabeprazole Related Compound F VL970005View CAS 168167-42-8
Rabeprazole Rabeprazole Related compound A VL970011View CAS 1163685-30-0 (free acid)
Rabeprazole Rabeprazole Sodium R-Isomer VE0010116View CAS 171440-18-9
Rabeprazole Rabeprazole Sodium STAGE - I VL970002View CAS 117976-90-6
Rabeprazole 2-(Chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine 1-oxide VE009625View CAS 924663-39-8

Rabeprazole Related Compound

Rabeprazole is a drug that reduces stomach acid. It is used to treat peptic ulcers, gastroesophageal reflux disease, and excessive stomach acid production, such as in Zollinger-Ellison syndrome.

References

FAQ

What is the drug rabeprazole used for?

Rabeprazole is used to treat duodenal ulcers, gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome, a disorder in which the stomach generates excessive amounts of acid. It may also be used in conjunction with antibiotics (e.g., amoxicillin, clarithromycin) to treat ulcers produced by H. influenzae infections.

Is rabeprazole a type of antacid?

Rabeprazole is part of a class of drugs known as proton-pump inhibitors. It reduces the quantity of acid produced in the stomach.

What is the mechanism of action of rabeprazole?

Rabeprazole is a proton pump inhibitor antiulcer medication. It is a prodrug that converts to active sulphenamide in the acid environment of the parietal cells. Rabeprazole inhibits the H+, K+ATPase of coated gastric cells and suppresses basal and induced stomach acid output in a dose-dependent manner.

Request a quote

102804-77-3: Rabeprazole EP Impurity E

102804-77-3: Rabeprazole EP Impurity E
Catalogue No.

VL970013

CAS No.

102804-77-3

Molecular Formula

C15H15N3O2S

Molecular Weight

301.36

Parent drug

Rabeprazole

IUPAC Name

2-[[(4-Methoxy-3-methyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole

Synonyms

Rabeprazole 4-Methoxy Impurity / 4-Desmethoxypropoxyl-4-Methoxy Rabeprazole

References

Pace, Fabio, et al. “A Review of Rabeprazole in the Treatment of Acid-Related Diseases.” Therapeutics and Clinical Risk Management, vol. 3, no. 3, Dove Medical Press, 2007, pp. 363–79, http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2386363/. ?

Status

In-stock

ListName

Rabeprazole EP Impurity E

Exclusively Supplied by Veeprho

Exclusively Supplied by Veeprho

"*" indicates required fields

Hidden
Products quotation
Name
Url